Molecular Mechanisms of and Possible Treatment Strategies for Idiopathic Pulmonary Fibrosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|30|3943-3971

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.30, 2005-11, pp. : 3943-3971

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.  

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite

New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis

By Ding Qiang   Luckhardt Tracy   Hecker Louise   Zhou Yong   Liu Gang   Antony Veena B.   deAndrade Joao   Thannickal Victor J.  

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 981-1001

Adis International

Access to resources Recommend Favorite

Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 3, 2010-07 ,pp. : 158-172

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Molecular Targets and Treatment of Idiopathic Pulmonary Fibrosis: Focus on TGF&bgr; Signaling and the Myofibroblast

By  

Current Medicinal Chemistry, Vol. 16, Iss. 11, 2009-04 ,pp. : 1400-1417

Bentham Science Publishers

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite